Aerie Pharmaceuticals - OIS@AAO 2015

Aerie Pharmaceuticals - OIS@ASCRS 2015Подробнее

Inotek Pharmaceuticals - OIS@AAO 2015Подробнее

Aerie Pharmaceuticals Using ROCK Inhibitors to Change Glaucoma Management (OIS@AAO 2016)Подробнее

Aerie Pharmaceuticals: Moving Beyond Glaucoma (OIS@ASRS 2016)Подробнее

Aerie PharmaceuticalsПодробнее

RetroSense Therapeutics - Companies to Watch - OIS@AAO 2015Подробнее

Clinical Progress of Aerie Pharmaceuticals’ Rhopressa and RoclatanПодробнее

A View from the AAO - OIS@AAO 2015Подробнее

Aerie Pharmaceuticals - Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019Подробнее

Ophthotech Corporation - OIS@AAO 2015Подробнее

Vince Anido, PhD of Aerie Pharmaceuticals Discusses New Product Lines at OIS@ASRS 2019Подробнее

Welcome & Chairman's 2015 Year in Review - OIS@AAO 2015Подробнее

Aerie COO Mitro Provides Staffing, Pipeline UpdateПодробнее

Envisia Therapeutics - OIS@AAO 2015Подробнее

Aerie Pharmaceuticals - Public Company Showcase at Ophthalmology Innovation Summit @ ASRS 2019Подробнее

Novaliq - Companies to Watch - OIS@AAO 2015Подробнее

Digital Ophthalmology Sector Overview - OIS@AAO 2015Подробнее

Aerie: Bringing Rhopressa and Roclatan into US glaucoma markeПодробнее